New Guidance on Alpha-Gal Syndrome’s GI Implications: What to Know

Australia News News

New Guidance on Alpha-Gal Syndrome’s GI Implications: What to Know
Australia Latest News,Australia Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 86 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 55%

Knowing more about this allergy triggered by a tick bite will help physicians both in the US and globally with their differential diagnoses, according to Dr David Johnson.

Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia.The American Gastroenterological Association just releasedBackground on This Emerging Allergy

Surprisingly, the sensitization comes through exposure to a tick bite, and in the United States, the lone star tick has been the most commonly implicated. Reported cases are primarily found in the lone star tick's range from the Midwest to the East, with the only region of relative exclusion being the far Northeast.

Conversely, clinicians should consider not testing those with"red flag" symptoms, particularly people who have anemia, GI bleeding, and weight loss. The allergy doesn't cause these types of symptoms, so you wouldn't seek to diagnostically identify alpha-gal in those situations. This diet should focus on things like mammalian products , and related mammalian-derived products , and be followed for at least a month. And, as we do with our patients with celiac disease, it's very important to caution those with alpha-gal syndrome to avoid eating at restaurants during this time, because they can easily cross-contaminate with food and processed foods, in the form of food additives that otherwise may be missed.

There have been some patients who have reported reactions from just the inhalation of the alpha-gal; for example, from frying bacon or beef products. These may be things to counsel patients about too. There are alpha-gal–free medical device products available, so this is something for those who are performing transplants or vascular surgeons to be aware of, especially if you're practicing in an endemic area and patients may be showing this proclivity.For gastroenterologists following up with patients with alpha-gal syndrome, it's important to recognize that this is a dynamic condition. Symptoms may fluctuate over time.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Johnson & Johnson beats Q1 consensus estimates and raises guidanceJohnson & Johnson beats Q1 consensus estimates and raises guidanceJohnson & Johnson’s stock rose 1.4% in premarket trade Tuesday, after the consumer health and pharma company beat consensus estimates for its first quarter...
Read more »

JNJ Stock Price | Johnson & Johnson Stock - Investing.comJNJ Stock Price | Johnson & Johnson Stock - Investing.comGet today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.
Read more »

Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 OutlookJohnson & Johnson Posts Higher Quarterly Sales, Raises 2023 OutlookFirst-quarter earnings were wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.
Read more »

Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and moreStocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and moreShares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell.
Read more »

Johnson & Johnson beats on earnings and revenue, raises full-year guidanceJohnson & Johnson beats on earnings and revenue, raises full-year guidanceEARNINGS: J&J reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year forecast. CFO Joseph Wolk joins us to discuss.
Read more »

Why the pros say there's still a lot of upside to Johnson & Johnson after earnings beatWhy the pros say there's still a lot of upside to Johnson & Johnson after earnings beatAnalysts and investors took to CNBC to discuss the latest action for Johnson & Johnson shares.
Read more »



Render Time: 2025-02-27 19:43:12